Tumor Transcriptome Sequencing Reveals Allelic Expression Imbalances Associated with Copy Number Alterations-Reference-Cited by-同舟云学术

Tumor Transcriptome Sequencing Reveals Allelic Expression Imbalances Associated with Copy Number Alterations

Published:2010-02-19 Issue:2 Volume:5 Page:e9317
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tuch Brian B.,Laborde Rebecca R.,Xu Xing,Gu Jian,Chung Christina B.,Monighetti Cinna K.,Stanley Sarah J.,Olsen Kerry D.,Kasperbauer Jan L.,Moore Eric J.,Broomer Adam J.,Tan Ruoying,Brzoska Pius M.,Muller Matthew W.,Siddiqui Asim S.,Asmann Yan W.,Sun Yongming,Kuersten Scott,Barker Melissa A.,De La Vega Francisco M.,Smith David I.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference73 articles.

1. RNA-Seq: a revolutionary tool for transcriptomics.;Z Wang;Nat Rev Genet,2009

2. Whole-genome re-sequencing.;DR Bentley;Curr Opin Genet Dev,2006

3. Mapping and quantifying mammalian transcriptomes by RNA-Seq.;A Mortazavi;Nat Methods,2008

4. Alternative isoform regulation in human tissue transcriptomes.;ET Wang;Nature,2008

5. Allelic imbalance sequencing reveals that single-nucleotide polymorphisms frequently alter microRNA-directed repression.;J Kim;Nat Biotechnol,2009

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Normalization of gene counts affects principal components-based exploratory analysis of RNA-sequencing data;Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms;2024-12

2. Allele-specific expression is selected in tumorigenesis, results from epigenetic changes and has prognostic relevance;2024-09-09

3. Transfer Learning in Multiple Hypothesis Testing;Entropy;2024-01-04

4. Circulating cell-free DNA in oral squamous cell carcinoma patients allows for non-invasive prognosis and identification of structural variants, novel chimeras and oncoviruses;2023-11-30

5. Evaluating Fate of Emerging Resistance Hitting the Brakes on Conventional Treatment Approach;Therapeutic Drug Targets and Phytomedicine For Triple Negative Breast Cancer;2023-01